
ETF
iShares Nasdaq US Biotech ETF USD Dist
- ISIN
- IE00BDZVHG35
- Category
- Sector Equity Biotechnology
How good is this fund, really?
See the rating in the appAbout iShares Nasdaq US Biotech ETF USD Dist
Only companies listed on the NASDAQ Stock Market and classed as biotechnology or pharmaceutical businesses can enter the NASDAQ Biotechnology Index, the benchmark of iShares Nasdaq US Biotech ETF USD Dist. Members must also pass NASDAQ, Inc.'s size and liquidity tests. No constituent may exceed 8% of the index, and at most five can sit at that level. The passive BlackRock fund aims to hold the index shares in similar proportions. Income is paid semi-annually in US dollars. The fund was launched in 2017 and this class in 2018, under iShares IV plc. Its ongoing charge is 0.35%, and the key investor information document assigns a risk level of 6 out of 7.
Watch this fund for free Add iShares Nasdaq US Biotech ETF USD Dist to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.
Watch the fund for freeWhere to buy iShares Nasdaq US Biotech ETF USD Dist — platforms and fees
Sold on 2 platforms we follow.
-
AJ Bell Annual fee: See the platformGo to AJ Bell ↗
-
interactive investor Annual fee: See the platformGo to interactive investor ↗
iShares Nasdaq US Biotech ETF USD Dist — its category
Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.
Biotechnology funds →Other funds
- First Trust NYSE Arca Biotech ETFAUSDAcc
- Franklin Biotechnology Discv Z(acc)GBP
- Global X Genomics & Biotech ETF USD Acc
- International Biotechnology Ord
- Invesco NASDAQ Biotech ETF
- iShares Nasdaq US Biotech ETF USD Acc
- Janus Henderson Hrzn Biotec H2 USD
- JPM Thmtcs Gentc Thrps C dist GBP
- L&G Pharma Breakthrough ETF
- LS ARK Genomic Revolution Trkr ETP Scs
- Pictet-Biotech I dy GBP
- Polar Capital Biotech I Inc